News | News By Subject | News by Disease News By Date | Search News

Diabetic retinopathy News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Genentech (RHHBY)'s Lucentis Is the First Drug to Win Approval for Diabetic Retinopathy     2/10/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Alimera Sciences, pSivida Limited (PSD.AX) Amend Medidur(TM) FA Collaboration Agreement     3/17/2008
Eli Lilly and Company (LLY) Announces FDA Requirement Of Additional Clinical Trial Before Ruboxistaurin Could Be Approved For Treatment Of Diabetic Retinopathy     9/29/2006
Eli Lilly and Company (LLY) Announces Approvable Letter Issued By FDA For Arxxant(TM) (ruboxistaurin mesylate); FDA Requests Further Data Before Approval     8/18/2006
Isis Pharmaceuticals, Inc. (ISIS) Licenses Antisense Drug To iCo Therapeutics For The Treatment Of Eye Diseases     8/25/2005
Eli Lilly and Company (LLY) Will Submit Ruboxistaurin Mesylate (Arxxant(TM)) To FDA For Treatment Of Diabetic Retinopathy In 2005; Mixed Results; Will Not Pursue Submission For Treatment Of Symptoms Of Diabetic Peripheral Neuropathy     8/2/2005
Genentech, Inc. (DNA) Release: Phase III Study Shows Lucentis(TM) Improved Vision In Patients With Wet Age-Related Macular Degeneration     7/18/2005
FDA Grants ISTA Pharmaceuticals' (ISTA) Vitrase Five-Year Market Exclusivity     10/28/2004

News from Around the Web
Google (GOOG)'s AI Reads Retinas To Prevent Blindness In Diabetics     11/30/2016
Painkiller May Prevent Diabetes-Related Retinal Damage; Pentazocine's Effects On Eye Health Called 'Phenomenal,' Medical College of Georgia Study Concludes     9/24/2008
Eye Abnormality Elevates Heart Disease Death Risk, University of Sydney, University of Melbourne, and National University of Singapore Study     8/13/2008
National Institutes of Health (NIH): Older Treatment May Be More Effective in Preserving Sight for Some Patients with Diabetes     7/29/2008
The Day In Review: Amylin Pharmaceuticals, Inc. (AMLN) Falls On Byetta Shortfall     7/21/2006
Molecule Linked To Vision Loss In Diabetics     8/25/2005
Joslin-Chaired Study Shows New Compound May Reduce Risk Of Vision Loss In Patients With Diabetes     7/14/2005
Diabetic Eye Disease May Foreshadow Amputation     11/12/2003

Press Releases
Allegro Ophthalmics LLC Announces Last Patient Enrolled In PACIFIC Phase IIb Clinical Trial Of Luminate For Non-Proliferative Diabetic Retinopathy     10/3/2016
Acucela Initiates Phase 2 Clinical Trial Addressing Proliferative Diabetic Retinopathy     5/9/2016
Eyenuk Release: Large UK National Health Services (NHS) Study Finds EyeArt Device To Be the Most Sensitive Automated Retinal Image Analysis Technology For Diabetic Retinopathy Screening     5/2/2016
Breakthrough Handheld Technology From Welch Allyn Makes Diabetic Retinopathy Screening Simple And Affordable For Primary Care Settings     3/23/2016
Aerpio Announces Presentation Of Positive Results Of AKB-9778 In Patients With Diabetic Retinopathy From TIME-2 Phase IIa Study     2/10/2016
Alimera Sciences (ALIM) Announces New 36-Month Analysis That Shows ILUVIEN Slows Diabetic Retinopathy Progression     11/16/2015
Allegro Ophthalmics LLC Begins Phase II Clinical Study Of Luminate® For Non-Proliferative Diabetic Retinopathy     5/4/2015
FDA Approves Genentech (RHHBY)’s Lucentis (Ranibizumab Injection) For Treatment Of Diabetic Retinopathy In People With Diabetic Macular Edema     2/9/2015
Acucela Inc. Announces Experimental Eye Research Publication; Paper Outlines First Demonstrated Effect of Visual Cycle Modulation Treatment on Retinopathy     8/9/2010
pSivida Limited (PSD.AX) Announces Interim Results from the Three-Month Readout of the Human PK MedidurTM FA Study     6/26/2008
Pipex Pharmaceuticals (PPXP) Executes Option to License Oral Flupirtine Patent Estate for Diabetes, Diabetic Retinopathy, Retinitis Pigmentosa and Glaucoma     5/28/2008
VitreoRetinal Technologies Inc. Announces the Enrollment of First Patients for Its Phase III Clinical Trial for Vitreosolve for Diabetic Retinopathy Patients in the U.S. and India     4/4/2008
MacuSight, Inc. Announces Positive Initial Results From Phase 1 Study of Sirolimus in Diabetic Macular Edema     10/1/2007
Bausch & Lomb (BOL) Introduces Ocuvite(R) DF Eye Vitamin Supplement for Diabetics     6/28/2007
Eli Lilly and Company (LLY) Release: Investigational Treatment Ruboxistaurin Demonstrated Promise In Reducing The Occurrence Of Vision Loss Caused By Diabetic Retinopathy     6/12/2006

//-->